Cingulate News

Cingulate Inc (CING) Receives a Hold From Maxim Group

TipRanksApr 4 23:05

HC Wainwright & Co. Maintains Buy on Cingulate, Raises Price Target to $8

BenzingaJan 5 20:44

Cingulate Analyst Ratings

BenzingaJan 5 20:40

Laidlaw Cuts Cingulate to Hold, Cites Dwindling Resources

Seeking AlphaDec 23, 2023 05:15

Cingulate Analyst Ratings

BenzingaDec 22, 2023 17:40

Cingulate Analyst Ratings

BenzingaDec 19, 2023 00:36

Cingulate Inc's Strong Financial Position and Promising ADHD Drug Development Prospects Garner Buy Rating From Maxim Group

TipRanksNov 17, 2023 04:45

Analysts Offer Insights on Healthcare Companies: Cano Health (CANO), Personalis (PSNL) and Cingulate Inc (CING)

TipRanksOct 25, 2023 18:20

HC Wainwright & Co. Maintains Buy on Cingulate, Lowers Price Target to $3.5

BenzingaSep 26, 2023 18:27

Cingulate Analyst Ratings

BenzingaSep 26, 2023 18:25

Analysts Are Bullish on Top Healthcare Stocks: Cingulate Inc (CING), Achieve Life Sciences (ACHV)

TipRanksJul 13, 2023 19:40

Maxim Group Reaffirms Their Buy Rating on Cingulate Inc (CING)

TipRanksJun 9, 2023 22:35

Maxim Group Remains a Buy on Cingulate Inc (CING)

TipRanksMay 12, 2023 22:25

Maxim Group Keeps Their Buy Rating on Cingulate Inc (CING)

TipRanksMay 5, 2023 22:56

Maxim Group Keeps Their Buy Rating on Cingulate Inc (CING)

TipRanksFeb 25, 2023 20:40

Cingulate Analyst Ratings

Benzinga Analyst RatingsJan 17, 2023 19:26

Maxim Group Remains a Buy on Cingulate Inc (CING)

TipRanksDec 9, 2022 04:40

Maxim Starts Cingulate at Buy With $3 Price Target

MT NewswiresNov 22, 2022 22:43

Maxim Group Initiates Coverage On Cingulate With Buy Rating, Announces Price Target of $3

Benzinga Real-time NewsNov 22, 2022 21:25

Cingulate Analyst Ratings

Benzinga Analyst RatingsNov 22, 2022 21:22